Investec Bank plc has filed a Form 8.5 regulatory disclosure relating to share dealings in Advanced Medical Solutions Group plc (AMS.L), as required under Rule 8.5 of the Takeover Code.
The disclosure covers transactions undertaken on 3rd June 2026, with the filing itself published on 4th June 2026 by contact Abhishek Gawde.
Investec Bank plc acted in its capacity as an exempt principal trader with recognised intermediary status, dealing in a client-serving capacity during the relevant period.
The bank holds a significant advisory relationship with the company, serving as both Advisor and Joint Broker to Advanced Medical Solutions Group plc.
According to the filing, Investec purchased a total of 61,502 ordinary shares in Advanced Medical Solutions Group, with prices ranging between 214 pence and 215 pence per unit.
In the same period, the bank also sold 61,502 ordinary shares, with prices ranging between 214.5 pence and 215 pence per unit, reflecting balanced client-serving activity.
The matched volume of purchases and sales is consistent with the nature of exempt principal trader activity conducted on behalf of clients in the open market.
No cash-settled derivative transactions, stock-settled derivative transactions, or options were reported as part of this disclosure filing.
Investec confirmed that no indemnity arrangements, option agreements, or formal and informal understandings relating to relevant securities were entered into in connection with this disclosure.
Similarly, the bank confirmed no agreements or understandings exist concerning voting rights or future acquisition and disposal of relevant securities to which any derivative is referenced.
Shares in Advanced Medical Solutions Group (AMS.L) moved 2.08% on the day, according to data accompanying the regulatory announcement on 4th June 2026.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service to maintain market transparency.
